Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Ion G. Motofei. (2022) Nobel Prize for immune checkpoint inhibitors, understanding the immunological switching between immunosuppression and autoimmunity. Expert Opinion on Drug Safety 21:5, pages 599-612.
Read now
Read now
Luke D. Rothermel & Jonathan S. Zager. (2018) Engineered oncolytic viruses to treat melanoma: where are we now and what comes next?. Expert Opinion on Biological Therapy 18:12, pages 1199-1207.
Read now
Read now
Articles from other publishers (7)
Nouf Alluqmani, Anna Jirovec, Zaid Taha, Oliver Varette, Andrew Chen, Daniel Serrano, Glib Maznyi, Sarwat Khan, Nicole E. Forbes, Rozanne Arulanandam, Rebecca C. Auer & Jean-Simon Diallo. (2022) Vanadyl sulfate-enhanced oncolytic virus immunotherapy mediates the antitumor immune response by upregulating the secretion of pro-inflammatory cytokines and chemokines. Frontiers in Immunology 13.
Crossref
Crossref
Jonathan Santos Apolonio, Vinícius Lima de Souza Gonçalves, Maria Luísa Cordeiro Santos, Marcel Silva Luz, João Victor Silva Souza, Samuel Luca Rocha Pinheiro, Wedja Rafaela de Souza, Matheus Sande Loureiro & Fabrício Freire de Melo. (2021) Oncolytic virus therapy in cancer: A current review. World Journal of Virology 10:5, pages 229-255.
Crossref
Crossref
James A. Davies, Gareth Marlow, Hanni K. Uusi-Kerttula, Gillian Seaton, Luke Piggott, Luned M. Badder, Richard W. E. Clarkson, John D. Chester & Alan L. Parker. (2021) Efficient Intravenous Tumor Targeting Using the αvβ6 Integrin-Selective Precision Virotherapy Ad5NULL-A20. Viruses 13:5, pages 864.
Crossref
Crossref
Konstantin G. Gurevich, Yulya A. Sorokina, Alexander L. Urakov, Darya M. Gavrilova, Lyubov V. Lovtsova & Olga V. Zanozina. (2020) Drugs for gene therapy: features of usage in geriatrics and pediatrics. Reviews on Clinical Pharmacology and Drug Therapy 18:3, pages 237-244.
Crossref
Crossref
Lizhi Li, Shixin Liu, Duoduo Han, Bin Tang & Jian Ma. (2020) Delivery and Biosafety of Oncolytic Virotherapy. Frontiers in Oncology 10.
Crossref
Crossref
Natalia V. Eremina, Vasily I. Kazey, Sergey V. Mishugin, Roman V. Leonenkov, Dmitry Y. Pushkar, Vadim L. Mett & Andrei V. Gudkov. (2020) First-in-human study of anticancer immunotherapy drug candidate mobilan: safety, pharmacokinetics and pharmacodynamics in prostate cancer patients. Oncotarget 11:14, pages 1273-1288.
Crossref
Crossref
N. K. Klaan, L. P. Аkin’shina & T. A. Pronina. (2019) Oncolitical viruses in the therapy of malignant neoplastic diseases. Russian Journal of Biotherapy 17:4, pages 6-19.
Crossref
Crossref